4162 Income Statement - TTM - PharmaEngine, Inc.

Income Statement (TTM)

PharmaEngine, Inc. Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.

All numbers are times 1,000,000 except per share units.

	2020 09-30	2020 12-31	2021 03-31	2021 06-30	2021 09-30	2021 12-31	2022 03-31	2022 06-30	2022 09-30	2022 12-31	2023 03-31	2023 06-30	2023 09-30	2023 12-31	2024 03-31	2024 06-30	2024 09-30	2024 12-31	2025 03-31	2025 06-30
Revenue	344	1,056	1,088	1,156	1,237	655	713	722	700	654	649	648	739	768	764	860	832	2,523	2,546	2,481
Change (%)		206.56	3.02	6.26	7.05	-47.08	8.93	1.21	-3.08	-6.48	-0.89	-0.13	14.06	3.91	-0.50	12.55	-3.22	203.31	0.91	-2.56
% of Revenue	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00

Cost Of Sales	35	37	37	38	39	37	40	42	45	50	52	52	50	49	46	45	46	48	49	48
Change (%)		5.38	0.59	2.17	1.21	-4.27	6.61	5.72	7.74	10.40	4.00	0.62	-3.58	-2.88	-5.30	-2.32	2.36	3.54	2.80	-1.50
% of Revenue	10.26	3.53	3.44	3.31	3.13	5.66	5.54	5.79	6.43	7.59	7.97	8.03	6.79	6.34	6.04	5.24	5.54	1.89	1.93	1.95

Gross Operating Profit	309	1,019	1,050	1,118	1,199	618	674	680	655	605	597	596	689	719	718	815	786	2,476	2,497	2,433
Change (%)		229.55	3.11	6.41	7.25	-48.47	9.07	0.95	-3.75	-7.64	-1.29	-0.19	15.60	4.40	-0.18	13.50	-3.53	215.03	0.87	-2.58
% of Revenue	89.74	96.47	96.56	96.69	96.87	94.34	94.46	94.21	93.57	92.41	92.03	91.97	93.21	93.66	93.96	94.76	94.46	98.11	98.07	98.05

SG&A	95	113	119	128	133	118	119	124	135	140	146	146	136	132	127	127	134	155	157	154
Change (%)		19.78	5.37	6.77	4.48	-11.30	0.96	3.89	8.86	3.80	4.58	-0.63	-6.67	-3.19	-3.40	0.33	5.38	15.68	0.78	-1.91
% of Revenue	27.47	10.73	10.98	11.03	10.77	18.05	16.73	17.17	19.28	21.40	22.58	22.47	18.39	17.13	16.63	14.83	16.14	6.16	6.15	6.19

R&D	98	96	118	119	136	137	110	108	151	182	203	247	291	310	327	333	259	267	266	250
Change (%)		-2.74	23.58	0.67	14.40	0.47	-19.84	-1.22	39.70	20.12	11.73	21.44	17.99	6.56	5.45	1.90	-22.39	3.20	-0.39	-5.88
% of Revenue	28.57	9.07	10.87	10.30	11.01	20.90	15.38	15.01	21.64	27.79	31.33	38.10	39.41	40.42	42.84	38.78	31.10	10.58	10.45	10.09

OpEx	228	246	275	285	308	292	269	274	331	372	401	444	477	490	500	506	439	470	472	452
Change (%)		7.85	11.73	3.52	8.19	-5.21	-8.07	2.07	20.88	12.15	8.00	10.71	7.39	2.79	2.01	1.11	-13.19	7.05	0.32	-4.11
% of Revenue	66.30	23.32	25.30	24.64	24.91	44.61	37.65	37.97	47.36	56.79	61.89	68.60	64.59	63.89	65.51	58.85	52.79	18.63	18.52	18.23

Operating Income	116	810	813	871	929	363	445	448	368	283	247	203	262	277	263	354	393	2,053	2,075	2,029
Change (%)		597.46	0.37	7.19	6.67	-60.97	22.63	0.69	-17.75	-23.24	-12.57	-17.72	28.63	5.94	-4.95	34.26	11.03	422.77	1.04	-2.21
% of Revenue	33.70	76.68	74.70	75.36	75.09	55.39	62.35	62.03	52.64	43.21	38.11	31.40	35.41	36.11	34.49	41.15	47.21	81.37	81.48	81.77

Interest Expense	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0
Change (%)		7.00	-22.35	-11.34	-13.44	-19.70	-22.17	-28.48	-37.29	4.05	87.01	46.53	31.75	11.51	-10.65	-11.19	-13.41	-15.02	-17.68	-18.79
% of Revenue	-0.12	-0.04	-0.03	-0.03	-0.02	-0.03	-0.02	-0.02	-0.01	-0.01	-0.02	-0.03	-0.04	-0.04	-0.04	-0.03	-0.03	-0.01	-0.01	-0.00

Net Income	45	604	631	782	837	426	447	362	377	319	303	298	291	275	275	359	370	1,751	1,772	1,631
Change (%)		1,253.89	4.44	23.97	7.00	-49.11	5.01	-19.00	3.95	-15.37	-4.91	-1.83	-2.25	-5.58	0.13	30.46	3.17	373.07	1.18	-7.96
% of Revenue	12.96	57.22	58.01	67.68	67.65	65.06	62.72	50.20	53.84	48.72	46.74	45.94	39.37	35.78	36.00	41.73	44.49	69.39	69.58	65.72

Source: Capital IQ

PharmaEngine, Inc. - Income Statement (TTM)

Income Statement (TTM)